L

LATE GROWTH STAGE

Late Growth Stage Program

Late Growth Stage (After Series A/B)

Course Overview

The phase after the Series A & B is all about growth. You can call this Series C, D, etc. You can also add “expansion” to the stage.

New investors at this stage can include more VC firms, “growth” equity firms, private equity firms, or any other large Hedge or Sovereign Wealth funds. Late stage companies tend to proceed toward a public offering in order to achieve an exit for its early investors.

The company machine is generally humming and needs more fuel (i.e., financing) to go faster. The risk calculus is very different, even from Series A and B, as it’s mostly about expanding a set of activities that are ideally already working.

You’re in this stage if you are:

Completely or nearly staffed

Experiencing significant growth

Looking for expansion opportunities

Considering an exit (M&A or IPO)

CEO360 Certification

At the end of 12 months, CEOs completing the requirements will receive a certification and recognition

Program Goals

CEO Benefits From The Program

Transferable Economics:

Managed Service/Internal Hires
ERP Upgrade
R&D PO Management Workflow
Audit Ready/Audited Financials
Month End Financial Statements by 15 days (Exec Summary, P&L, BS, CF, KPIs)
Due Diligence Ready

Competitive Greatness:

Market Research Supporting TPP Highlighting Significant Revenue Estimates Within 5 Years of Launch
Clinical studies support unique differentiation

Compelling Solutions:

Clinical/ Regulatory Filings Leading to Early Commercialization
Reimbursement Strategies
Go-To=Market Strategies
Pipeline Expansion

Championship Team:

Benefits & Perks Differentiators
Culture Building & Branding
Internal Talent Acquisition
Performance Management
Compliance Due to Headcount

Attractive Markets:

Large Markets With Room for Growth
Opportunity To Take Market Share
Unique, Niche Markets
Manageable Competitive Headwinds

Fund Raising:

Series B – C+
Equity priced rounds, institutional investors
$20mm+

Intellectual Property – Legal:

Licensing and Collaboration Agreements
Possible Purchase Agreements

GMP Manufacturing / Clinical Viability:

Understand GMP resupply timelines and tech transfers
Understand later phase CDMOs and their requirements. Different sites do different things.
Must have a CMC partner, not just a contractor for later phase studies.
If you have a pipeline, do you have primary and secondary CDMOs? GMP backup is a necessity

Month Twelve

Networking

PE Pitch Contest

PE Workshop

Program Details

Late Stage Growth Group
Price:	$3,000 per CEO
Partners:	TBD
Moderators:	David Crean • Tari Suprapto • John Foley
Company Stage:	Late Stage Growth
Frequency:	Monthly
Location:	TBD
Time:	8:30AM to 11:30AM
Calendar:	TBD

Enroll Now

Nominate a CEO

Nominate a Late Stage Growth CEO in the Life Sciences including pharmaceutical, biotechnology (small molecules, biologics, CGT), medical device, med tech, life sciences tools.

CEO360 is a moderated peer-to-peer advisory program where 20-25 Life Sciences CEOs meet monthly and collaborate to solve their toughest business issues.

L

LATE GROWTH STAGE

Late Growth Stage Program

Late Growth Stage (After Series A/B)

Program Goals

CEO Benefits From The Program

Program Modules

1.

Month One

2.

Month Two

3.

Month Three

4.

Month Four

5.

Month Five

6.

Month Six

7.

Month Seven

8.

Month Eight

9.

Month Nine

10.

Month Ten

11.

Month Eleven

12.

Month Twelve

Program Details

Enroll Now

CEO360 is a moderated peer-to-peer advisory program where 20-25 Life Sciences CEOs meet monthly and collaborate to solve their toughest business issues.

Contact CEO360

Programs

Site Links